Compare Johnson & Johnson (JNJ) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Star Bulk Carriers Corp — how do they compare? Johnson & Johnson trades at $261.49 (market cap $618.09B), while Star Bulk Carriers Corp trades at $29.8 (market cap $3.54B). The key difference: Johnson & Johnson is far larger — about 174.6× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays the higher dividend (6.17%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Star Bulk Carriers Corp for 24 Days on average.
| JNJ | SBLK | |
|---|---|---|
Market Cap | $618.09B | $3.54B |
Volume | 6,050,983 | 1,437,622 |
Sector | Health | Industrials |
52-Week High | $278.43 | $32.49 |
52-Week Low | $186.00 | $16.79 |
Typical Hold Time | 129 Days | 24 Days |
Enterprise Value | $646.37B | $4.22B |
Dividend Yield | 2.09% | 6.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.
JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.
Star Bulk Carriers (SBLK) trades at $29.70, up slightly by 0.03% today, with a bullish technical signal from moving averages and a neutral stance from oscillators. The company shows strong profitability with a net income margin of 23.87% and has beaten earnings estimates for the last three quarters. Recent news highlights robust Q2 results, a $0.90 dividend for H2 2026, and significant insider buying, reflecting confidence in the shipping sector's momentum.
The outlook for SBLK is positive, supported by earnings beats, a shareholder-friendly dividend policy, and analyst consensus leaning buy. Risks include exposure to volatile shipping rates and macroeconomic pressures on global trade. Investors may find value in its attractive valuation multiples and strong cash flow generation, but should monitor freight rate trends and competitive dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
